0.5% Kanamycin Eye Drops 10mL | Aminoglycoside Ocular Antibacterial Solution

kananmycin Eye Drops
  • Concentration: 0.5% Kanamycin (5 mg/ml)
  • Volume: 5ml or 10ml per bottle
  • Packaging: Sterile plastic dropper bottle, 1 bottle/box
  • Shelf Life: 24 months (unopened)

Click to add this item to cart.

Product Description

Product Name0.5% Kanamycin Eye Drops 10mL (Kanamycin Ophthalmic Solution)
Specification10mL sterile eye drops containing 0.5% (5 mg/mL) Kanamycin
Dosage FormSterile Ophthalmic Solution (Eye Drops — for topical ocular administration)
Active IngredientKanamycin (Aminoglycoside Antibacterial Agent)
Pharmacological ClassAntibacterial Ophthalmic Agent (Aminoglycoside)
Route of AdministrationTopical ocular (instilled into the conjunctival sac). Typically 1-2 drops in the affected eye(s) every 2-4 hours initially, then reduced as directed.
PackagingSterile multi-dose dropper bottle (10mL) with tamper-evident seal
StorageStore at room temperature (15°C-25°C), protected from light. Keep container tightly closed. Do not freeze. Discard within 4 weeks of first opening.
Shelf Life24 months unopened; discard within 4 weeks of first opening

Product Overview

0.5% Kanamycin Eye Drops is a sterile ophthalmic solution containing 0.5% (5 mg/mL) kanamycin. It is an antibacterial eye drop used for the topical management of bacterial eye infections affecting the ocular surface.

0.5% Kanamycin Eye Drops 10mL: What the Published Guidance Says

Fifteen ophthalmic products spanning anti-infective, anti-allergic, anti-inflammatory, antiviral and ocular-surface categories — including the two anti-infectives the WHO Model List names for conjunctivitis and infectious keratitis.

Buyers usually settle three things before ordering 0.5% Kanamycin Eye Drops 10mL: the pharmacopoeial monograph, the pack configuration, and the documents the destination authority will ask for.

  • Gentamicin eye drops 0.3% are on the Model List for ocular infection WHO lists gentamicin eye drops 0.3% (gentamicin sulfate) for infectious blepharitis, classified in the Access group of the AWaRe framework. The Expert Committee has specified amikacin, kanamycin, netilmicin and tobramycin as therapeutic alternatives under the gentamicin square-box listing. WHO eEML — Gentamicin (ophthalmological)
  • Trachoma and endophthalmitis have separate recommendations For trachoma the treatment of choice is a single oral dose of azithromycin, with topical azithromycin or tetracycline also indicated. For bacterial endophthalmitis, the listings for ceftazidime, ceftriaxone and vancomycin were extended to cover it as a first-choice option, with the Committee noting that intravitreal administration requires specialist training and adequate infrastructure. WHO eEML — Ofloxacin (ophthalmological)
  • Ofloxacin 0.3% — for keratitis, and extended to conjunctivitis Ofloxacin eye drops 0.3% are listed for infectious keratitis, and in 2021 the Expert Committee recommended expanding the indication to include conjunctivitis. Topical fluoroquinolones are the class the Committee endorsed for infectious keratitis. WHO eEML — Ofloxacin (ophthalmological)

These points are quoted because they shape how 0.5% Kanamycin Eye Drops 10mL is specified, labelled and purchased — including strength selection, pack size and the artwork wording. Confirm each one against the approved product information in your market before finalising a purchase order.

0.5% Kanamycin Eye Drops 10mL: Specification, Pack & Documentation Summary

Product Name0.5% Kanamycin Eye Drops 10mL (Kanamycin Ophthalmic Solution)
Specification10mL sterile eye drops containing 0.5% (5 mg/mL) Kanamycin
Dosage FormSterile Ophthalmic Solution (Eye Drops — for topical ocular administration)
Active IngredientKanamycin (Aminoglycoside Antibacterial Agent)
Pharmacological ClassAntibacterial Ophthalmic Agent (Aminoglycoside)
Route of AdministrationTopical ocular (instilled into the conjunctival sac). Typically 1-2 drops in the affected eye(s) every 2-4 hours initially, then reduced as directed.
StorageStore at room temperature (15°C-25°C), protected from light. Keep container tightly closed. Do not freeze. Discard within 4 weeks of first opening.
Therapeutic groupOphthalmic — Ophthalmic
ManufacturerSinophare Bio-technology Co., Ltd. (GMP, China)
Documentation suppliedCOA, HPLC/GC data, stability data, dossier package

The same therapeutic range is supplied in several presentations, so one purchase order can cover a mixed requirement: 0.1% Dexamethasone Sodium Phosphate Eye Drops 10mL, 5% Taurine Eye Drops 10mL, 1% Acyclovir Eye Drops 10mL, 0.5% Chloramphenicol Eye Drops 10mL, 0.3% Gentamicin Eye Drops 10mL, 0.5% Hypromellose Eye Drops 10mL, 2.5% Lincomycin Hydrochloride Eye Drops 10mL, 0.5% Moxifloxacin Hydrochloride Eye Drops 10mL.

How 0.5% Kanamycin Eye Drops 10mL Is Tested and Released

Products are manufactured and tested against USP, EP, BP and CP monographs, with incoming raw-material inspection, in-process monitoring and full finished-product testing.

0.5% Kanamycin Eye Drops 10mL is released against the pharmacopoeial monograph named on your order (USP, EP, BP or CP). Where no monograph exists for the exact presentation, the specification is agreed with you in writing before manufacture and is attached to the certificate of analysis.

Standardised GMP production workshops with an independent R&D laboratory and a complete quality-inspection centre.

Release testing on this presentation is built around:

  • Testing for sterility and bacterial endotoxins (parenterals and ophthalmics)
  • Testing for microbial limits and preservative efficacy (multi-dose presentations)
  • Testing for heavy metals and elemental impurities
  • Testing for packaging integrity and seal testing
  • Testing for description and identification
  • Testing for assay of the active substance

COA, HPLC and GC data, DMF and dossier packages, plus registration support documents for national marketing-authorisation filings.

How 0.5% Kanamycin Eye Drops 10mL Is Packed, Labelled and Shipped

  • Pack size: Sterile multi-dose dropper bottle (10mL) with tamper-evident seal. Non-standard pack sizes can be quoted against your artwork.
  • Storage: Store at room temperature (15°C-25°C), protected from light. Keep container tightly closed. Do not freeze. Discard within 4 weeks of first opening..
  • Shelf life: 24 months unopened; discard within 4 weeks of first opening. Stability data for the marketed pack is included in the dossier.
  • Labelling: artwork can be produced in English, Arabic, French, Russian and Spanish, with your own brand and language mix, subject to the labelling rules of the destination market.
  • Export: GMP certificate, COA, certificate of origin, packing list and, where required, the free-sale or marketing authorisation certificate from the country of manufacture.

Regulatory Support for 0.5% Kanamycin Eye Drops 10mL

Sinophare Bio-technology Co., Ltd. holds DML Number Jin20160068 (medicines) and Jin20160069 (paracetamol API).. That registration identifies the legal manufacturer on the certificate of analysis, the GMP certificate and the documents filed with your national medicines authority.

  • Batch manufacturing and packaging records released for inspection on request during supplier audits.
  • Re-test or renewal support when the marketing authorisation comes up for variation or renewal.
  • CTD dossier modules 1–5 in editable and PDF form, with the finished-product and API sections cross-referenced.
  • Site Master File and GMP certificate for the manufacturing workshops.
  • Method validation, stability protocol and the shelf-life justification for the marketed pack.

This page describes 0.5% Kanamycin Eye Drops 10mL as a product of the ophthalmic preparations used in WHO and MSF eye-care protocols family. A WHO or national listing is a supply-context fact, not an approval in your market; marketing authorisation remains specific to each country.

Questions We Are Asked About 0.5% Kanamycin Eye Drops 10mL

What pack size is available for 0.5% Kanamycin Eye Drops 10mL?

The reference pack is Sterile multi-dose dropper bottle (10mL) with tamper-evident seal. Non-standard blister, bottle and carton configurations are quoted against your artwork, matched to the stability data already held for the presentation.

What documentation comes with a shipment of 0.5% Kanamycin Eye Drops 10mL?

Each batch ships with a certificate of analysis covering description, identification, assay and related substances, plus stability data for the marketed pack and the GMP certificate of the manufacturing site. Shelf life: 24 months unopened; discard within 4 weeks of first opening.

Does the batch documentation for 0.5% Kanamycin Eye Drops 10mL support a registration filing?

Each batch ships with a certificate of analysis covering description, identification, assay and related substances, plus stability data for the marketed pack and the GMP certificate of the manufacturing site. Shelf life: 24 months unopened; discard within 4 weeks of first opening. The full CTD dossier and the authority assessment file are supplied as part of a registration order; routine shipments carry the COA and stability data only.

Can you supply trypan blue for cataract surgery?

Yes. Trypan blue ophthalmic solution is available for capsule staining, supplied with sterility documentation.

What documentation accompanies an ophthalmic order?

Batch COA covering assay, sterility and preservative content, plus stability data, DMF and dossier packages with registration support documents.

Companion Products — Ophthalmic

Browse the full Ophthalmic range; all Ophthalmic; the complete product catalogue.

Request a Quotation for 0.5% Kanamycin Eye Drops 10mL

Send the specification, pack size, quantity and destination market for 0.5% Kanamycin Eye Drops 10mL 10mL and we will confirm availability, lead time and documentation. Tender quantities and registration samples are handled on the same quotation.

Request a quotation

Sources & Regulatory Notes

Reference information only. The published guidance summarised on this page is quoted for professional and regulatory-context purposes and does not constitute medical advice, a prescribing recommendation or a promotion of any product for a particular indication. Prescribing decisions must follow the approved product information and national treatment guidelines in the market of use.

<< return to products